These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 499466)

  • 21. gamma-Hydroxybutyrate modulates synthesis and extracellular concentration of gamma-aminobutyric acid in discrete rat brain regions in vivo.
    Gobaille S; Hechler V; Andriamampandry C; Kemmel V; Maitre M
    J Pharmacol Exp Ther; 1999 Jul; 290(1):303-9. PubMed ID: 10381791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-inhibitory dopamine-receptors and central effects of apomorphine.
    Di Chiara G; Porceddu ML; Morelli M; Gessa GL
    Ann Ist Super Sanita; 1978; 14(1):111-22. PubMed ID: 756166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. gamma-Aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anticonvulsant spectra.
    Worms P; Depoortere H; Durand A; Morselli PL; Lloyd KG; Bartholini G
    J Pharmacol Exp Ther; 1982 Mar; 220(3):660-71. PubMed ID: 6278129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of an imidazobenzodiazepine (RO 15-1788) on aggressive behavior in mice].
    Vasar EE; Maĭmets MO; Riago LK; Nurk AM; Allikmets LKh
    Biull Eksp Biol Med; 1984 Oct; 98(10):441-3. PubMed ID: 6208949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A role of some central neurotransmitter systems in the mechanism of electroconvulsive shock action.
    Kleinrok Z; Wielosz M
    Pol J Pharmacol Pharm; 1985; 37(6):745-52. PubMed ID: 3008135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [GABA-ergic cortical component in the action of piracetam and cetyl GABA].
    Ostrovskaia RU; Molodavkin GM; Kovalev GI
    Biull Eksp Biol Med; 1982 Apr; 93(4):62-4. PubMed ID: 7082805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative characteristics of the nootropic action of fenibut and fepiron].
    Kovaleva EL
    Farmakol Toksikol; 1984; 47(1):20-3. PubMed ID: 6705902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. gamma-Butyrolactone effects on behavior induced by dopamine agonists.
    Ellinwood EH; Gonzalez AE; Dougherty GG
    Biol Psychiatry; 1983 Sep; 18(9):1023-32. PubMed ID: 6685535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of dextromethorphan on dopamine dependent behaviours in rats.
    Gaikwad RV; Gaonkar RK; Jadhav SA; Thorat VM; Jadhav JH; Balsara JJ
    Indian J Exp Biol; 2007 Aug; 45(8):712-9. PubMed ID: 17877148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The suppression of the cerebrovascular constrictor effects of malondialdehyde by GABA-ergic substances].
    Mirzoian SA; Akopian VP; Manukian AA
    Eksp Klin Farmakol; 1994; 57(5):16-7. PubMed ID: 7696894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopaminergic--GABA-ergic interaction in the nigrostriatal system.
    Koltai MZ; György L
    Acta Physiol Acad Sci Hung; 1981; 58(3):225-33. PubMed ID: 7348023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of transmitter mechanisms in the behavioural effects of angiotensin II.
    Georgiev V
    Pol J Pharmacol Pharm; 1990; 42(6):553-62. PubMed ID: 1983291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recordings of extracellular glutamate and gamma-aminobutyric acid in the striatum of non-anesthetized rats. K(+)-stimulation, its Ca(2+)-dependence and lack of effects of drugs acting on dopamine receptors.
    Welsch-Kunze S; Kleim J; Dietze S; Kuschinsky K
    Arzneimittelforschung; 1993 Feb; 43(2):85-91. PubMed ID: 8096135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of piracetam, a cyclic GABA analogue, on haloperidol-induced catalepsy in the rat.
    Balsara JJ; Bapat TR; Chandorkar AG
    Indian J Physiol Pharmacol; 1980; 24(3):227-32. PubMed ID: 7193183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of dopamine agonists on gamma-aminobutyric acid (GABA) turnover in the superior colliculus: evidence that nigrotectal GABA projections are under the influence of dopaminergic transmission.
    Melis MR; Gale K
    J Pharmacol Exp Ther; 1983 Aug; 226(2):425-31. PubMed ID: 6875856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A pharmacological analysis of the antiedematous action of GABA-ergic and opioidergic agents in craniocerebral trauma].
    Novikov VE; Iasnetsov VV
    Eksp Klin Farmakol; 1995; 58(6):67-9. PubMed ID: 8704619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of bradykinin on central dopamine receptors.
    Przesmycki K; Kleinrok Z
    Pol J Pharmacol Pharm; 1976; 28(6):673-8. PubMed ID: 1034925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Catalepsy in the rat after haloperidol and some new GABA-ergic agents].
    Vamvakidès A
    Agressologie; 1984 Oct; 25(9):1011-6. PubMed ID: 6542324
    [No Abstract]   [Full Text] [Related]  

  • 39. Participation of serotoninergic, GABA-ergic and opiate mechanisms in the genesis of amphetamine stereotypy.
    Petkov V; Markovska V
    Acta Physiol Pharmacol Bulg; 1984; 10(2):3-12. PubMed ID: 6237549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents.
    Millan MJ; Brocco M; Rivet JM; Audinot V; Newman-Tancredi A; Maiofiss L; Queriaux S; Despaux N; Peglion JL; Dekeyne A
    J Pharmacol Exp Ther; 2000 Jan; 292(1):54-66. PubMed ID: 10604931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.